Home
/
Upstream Bio, Inc.
/
Financials
/
Quarterly
Upstream Bio, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Upstream Bio, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$683.0K
Nov 5, 2025
Q2
2025
Jun 30, 2025
$937.0K
Aug 6, 2025
Q1
2025
Mar 31, 2025
$566.0K
May 6, 2025
Q3
2025
Sep 30, 2024
$607.0K
Nov 5, 2025
Q2
2025
Jun 30, 2024
$510.0K
Aug 6, 2025
Q1
2025
Mar 31, 2024
$640.0K
May 6, 2025
Q3
2024
Sep 30, 2023
$621.0K
Nov 7, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($33.75M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($39.97M)
Aug 6, 2025
Q3
2025
Jun 30, 2025
($39.97M)
Nov 5, 2025
Q3
2025
Mar 31, 2025
($27.27M)
Nov 5, 2025
Q2
2025
Mar 31, 2025
($27.27M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($27.27M)
May 6, 2025
Q3
2025
Sep 30, 2024
($15.99M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($14.68M)
Aug 6, 2025
Q3
2025
Jun 30, 2024
($14.68M)
Nov 5, 2025
Q3
2025
Mar 31, 2024
($10.89M)
Nov 5, 2025
Q1
2025
Mar 31, 2024
($10.89M)
May 6, 2025
Q2
2025
Mar 31, 2024
($10.89M)
Aug 6, 2025
Q3
2024
Sep 30, 2023
($3.10M)
Nov 7, 2024
Q3
2024
Jun 30, 2023
($2.54M)
Nov 7, 2024
Q3
2024
Mar 31, 2023
($3.06M)
Nov 7, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($37.83M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($44.35M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($32.01M)
May 6, 2025
Q3
2025
Sep 30, 2024
($18.89M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($17.54M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($15.01M)
May 6, 2025
Q3
2024
Sep 30, 2023
($9.39M)
Nov 7, 2024